‘Plausible’ link between AstraZeneca vaccine and rare blood clots, WHO committee says
The opinion by the subcommittee of WHO’s Global Advisory Committee on Vaccine Safety (GACVS) follows a review of latest information from the European Medicines Agency (EMA), the United Kingdom’s regulatory body MHRA, and other countries. The EMA concluded that unusual blood clots with low blood platelets should be listed as very rare side effects of the AstraZeneca vaccine, while the…
Read More
